Frontiers in Immunology | Cancer Immunity and Immunotherapy

Mini Review

Published on 17 Jan 2025

New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma

in Cancer Immunity and Immunotherapy

Cong Luo
Xingxing Min
Danying Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1539696

985 views

Original Research

Published on 17 Jan 2025

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study

in Cancer Immunity and Immunotherapy

Yuchen Wang
Xiaobo Ma
Kewei Ma
Xi Chen
Hua He
Xiangye Zhao
Mengge Fan
Yinghui Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1479263

579 views

Original Research

Published on 17 Jan 2025

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies

in Cancer Immunity and Immunotherapy

Fu Zhao
Xiaojing Jiang
Yumeng Li
Tianjiao Huang
Zhikai Xiahou
Wenyang Nie
Qian Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500153

995 views

Original Research

Published on 17 Jan 2025

High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models

in Cancer Immunity and Immunotherapy

Hak Su Kim
Seung-hyun Kwon
Ok Kyung Choi
Taekyu Lim

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512605

1,167 views

Original Research

Published on 17 Jan 2025

Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies

in Cancer Immunity and Immunotherapy

Apolline Lefèvre
Zinnia P. Parra-Guillen
Iñaki F. Trocóniz
Christophe Boetsch
Nicolas Frances

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463915

814 views

Original Research

Published on 17 Jan 2025

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC

in Cancer Immunity and Immunotherapy

Haotian Qin
Juan Xu
Yaohang Yue
Meiling Chen
Zheng Zhang
Panpan Xu
Yan Zheng
Hui Zeng
Jian Weng
Jun Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456649

1,134 views
1 citation

Clinical Trial

Published on 17 Jan 2025

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

in Cancer Immunity and Immunotherapy

Meng Zhang
Xiaomei Zhang
Jiaxi Wang
Wenyi Lu
Xia Xiao
Hairong Lyu
Xiaoyuan He
Yedi Pu
Juanxia Meng
Cuicui Lyu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491341

1,048 views

Systematic Review

Published on 16 Jan 2025

A bibliometric study on the impact of gut microbiota on the efficacy of immune checkpoint inhibitors in cancer patients: analysis of the top 100 cited articles

in Cancer Immunity and Immunotherapy

Ziqi Zhao
Kun Xu
Boqian Hu
Yizhuo Jiang
Xisheng Xu
Yuliang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1519498

1,077 views

Original Research

Published on 16 Jan 2025

The impact of CD3ζ ITAM multiplicity and sequence on CAR T-cell survival and function

in Cancer Immunity and Immunotherapy

Shubhabrata Majumdar
Hilda Echelibe
Maria Bettini
Matthew L. Bettini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1509980

1,040 views

Original Research

Published on 16 Jan 2025

Evaluating the influence of anti-PD-1 immunotherapy combined with IMRT on thyroid dysfunction in nasopharyngeal carcinoma

in Cancer Immunity and Immunotherapy

Liqianqi Chen
Zihuang Li
Xianming Li
Shihai Wu
Long Gong
Gang Xu
Shanyi Chen
Yucong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495946

659 views

Original Research

Published on 16 Jan 2025

GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis

in Cancer Immunity and Immunotherapy

Dušica Ristić
Thomas Bärnthaler
Eva Gruden
Melanie Kienzl
Laura Danner
Karolina Herceg
Arailym Sarsembayeva
Julia Kargl
Rudolf Schicho

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513547

1,007 views

Original Research

Published on 15 Jan 2025

DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Qianxue Wu
Qian Xiao
Xin Tang
Liuying Li
Daqiang Song
Yang Zhou
Benhua Li
Guosheng Ren
Fang Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1516457

885 views

Original Research

Published on 15 Jan 2025

Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival

in Cancer Immunity and Immunotherapy

Jana Wellhausen
Louisa Röhl
Michael Berszin
Irene Krücken
Veit Zebralla
Markus Pirlich
Matthaeus Stoehr
Susanne Wiegand
Andreas Dietz
Theresa Wald

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473897

763 views

Original Research

Published on 15 Jan 2025

Characterization of NOD-like receptor-based molecular heterogeneity in glioma and its association with immune micro-environment and metabolism reprogramming

in Cancer Immunity and Immunotherapy

Chunlin Lu
Huihao Ma
Jie Wang
Fei Sun
Mingyang Fei
Ying Li
Jing Liu
Bin Dong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498583

791 views

Original Research

Published on 14 Jan 2025

Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma

in Cancer Immunity and Immunotherapy

Junchen Liu
Kun Dai
Muhammad Auwal Saliu
Mansur Dabai Salisu
Jiangyu Gan
Lukman Olalekan Afolabi
Dehong Yan
Guizhong Zhang
Maoxuan Liu
Xiaochun Wan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1519777

1,102 views

Original Research

Published on 14 Jan 2025

Epigenetic profiling for prognostic stratification and personalized therapy in breast cancer

in Cancer Immunity and Immunotherapy

Xiao Guo
Chuanbo Feng
Jiaying Xing
Yuyan Cao
Tengda Liu
Wenchuang Yang
Runhong Mu
Tao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1510829

604 views

Navigation group

Articles

New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies

High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models

Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

A bibliometric study on the impact of gut microbiota on the efficacy of immune checkpoint inhibitors in cancer patients: analysis of the top 100 cited articles

The impact of CD3ζ ITAM multiplicity and sequence on CAR T-cell survival and function

Evaluating the influence of anti-PD-1 immunotherapy combined with IMRT on thyroid dysfunction in nasopharyngeal carcinoma

GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis

DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma

Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival

Characterization of NOD-like receptor-based molecular heterogeneity in glioma and its association with immune micro-environment and metabolism reprogramming

Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma

Epigenetic profiling for prognostic stratification and personalized therapy in breast cancer